News

Published on 13 Aug 2023 on Insider Monkey via Yahoo Finance

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript


Article preview image

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript August 10, 2023

Onconova Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.29.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter [Technical Difficulty]

NASDAQ.ONTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript August 10, 2023 Oncono...

Insider Monkey via Yahoo Finance 13 Aug 2023

Onconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Z...

Zacks via Yahoo Finance 15 May 2023

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2022 Earnings Call Transcript

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2022 Earnings Call Transcript March 16, 2023 Operato...

Insider Monkey via Yahoo Finance 18 Mar 2023

Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer...

Onconova Therapeutics Inc (NASDAQ: ONTX) announced that the second of two evaluable participants ...

Benzinga via Yahoo Finance 7 Feb 2023

Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.26 per share versus the Z...

Zacks via Yahoo Finance 14 Nov 2022

Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.19 per share versus the Z...

Zacks via Yahoo Finance 11 Aug 2022

Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

Regulus Therapeutics Inc. RGLS announced that the FDA has accepted the investigational new drug...

MSN News 16 May 2022

Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

Regulus Therapeutics Inc. RGLS announced that the FDA has accepted the investigational new drug (...

Zacks via Yahoo Finance 12 May 2022

Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y

Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 12 cents per share in the first quarter ...

Zacks via Yahoo Finance 12 May 2022

Research Analysts’ New Coverage for May 10th (ACU, ACY, ADC, ADXS, AMPE, AMXEF, ATHA, BMWYY, BRCK,...

Research Analysts’ new coverage for Tuesday, May 10th: StockNews.com began coverage on shares of...

ETF DAILY NEWS 10 May 2022